First Time Loading...

Biomerieux SA
PAR:BIM

Watchlist Manager
Biomerieux SA Logo
Biomerieux SA
PAR:BIM
Watchlist
Price: 99.25 EUR 0.15% Market Closed
Updated: May 9, 2024
Section:
 

Relative Value

The Relative Value of one BIM stock under the Base Case scenario is 116.32 EUR. Compared to the current market price of 99.25 EUR, Biomerieux SA is Undervalued by 15%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BIM Relative Value
Base Case
116.32 EUR
Undervaluation 15%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.2
P/S
P/S
Price to Sales
3.2
vs History
77
vs Industry
38
Median 3Y
3.3
Median 5Y
3.4
Industry
2.4
Forward
3
More Details
32.8
P/E
P/E
Price to Earnings
32.8
vs History
38
vs Industry
17
Median 3Y
24.9
Median 5Y
30.9
Industry
23.4
Forward
24.1
More Details
26.3
P/OCF
P/OCF
Price to OCF
26.3
vs History
22
vs Industry
16
Median 3Y
21.7
Median 5Y
22.6
Industry
15.5
More Details
162.2
P/FCFE
P/FCFE
Price to FCFE
162.2
vs History
22
vs Industry
3
Median 3Y
67.4
Median 5Y
56.5
Industry
23.2
More Details
3.1
P/B
P/B
Price to Book Value
3.1
vs History
80
vs Industry
29
Median 3Y
3.2
Median 5Y
4.2
Industry
2.3
More Details
3.3
EV/S
EV/S
Enterprise Value to Sales
3.3
vs History
68
vs Industry
35
Median 3Y
3.3
Median 5Y
3.5
Industry
2.5
Forward
3
More Details
5.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.8
vs History
65
vs Industry
39
Median 3Y
5.7
Median 5Y
6.2
Industry
5.3
More Details
18.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
18.3
vs History
36
vs Industry
20
Median 3Y
16.1
Median 5Y
16.8
Industry
12.6
Forward
13.4
More Details
27.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
27.4
vs History
25
vs Industry
17
Median 3Y
18.6
Median 5Y
22.7
Industry
17.2
Forward
19.4
More Details
27
EV/OCF
EV/OCF
Enterprise Value to OCF
27
vs History
22
vs Industry
16
Median 3Y
21.7
Median 5Y
22.7
Industry
15.3
More Details
112.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
112.3
vs History
7
vs Industry
4
Median 3Y
41.4
Median 5Y
51.5
Industry
19.8
More Details
2.4
EV/IC
EV/IC
Enterprise Value to IC
2.4
vs History
95
vs Industry
33
Median 3Y
2.6
Median 5Y
2.9
Industry
2
More Details

Multiples Across Competitors

BIM Competitors Multiples
Biomerieux SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Biomerieux SA
PAR:BIM
11.7B EUR 3.2 32.8 18.3 27.4
US
Abbott Laboratories
NYSE:ABT
182.5B USD 4.5 32.4 19.2 28.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
136.9B USD 18.7 68.9 56.5 71.1
US
Stryker Corp
NYSE:SYK
126.3B USD 6 37.6 24.4 30.1
IE
Medtronic PLC
NYSE:MDT
109.5B USD 3.4 26.1 13.9 19.6
US
Boston Scientific Corp
NYSE:BSX
108.6B USD 7.4 61.5 30.9 45.7
US
Becton Dickinson and Co
NYSE:BDX
67.8B USD 3.5 55.8 18.6 39.5
DE
Siemens Healthineers AG
XETRA:SHL
58.5B EUR 2.7 38.5 18.5 31.2
US
Edwards Lifesciences Corp
NYSE:EW
52.6B USD 8.6 37.2 27 28.9
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
367.2B CNY 10.7 32.4 28.2 28.2
US
Dexcom Inc
NASDAQ:DXCM
51.1B USD 13.5 80 59.7 78.4

See Also

Summary
BIM intrinsic value, competitors valuation, and company profile.
DCF Valuation
BIM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BIM stock valuation using valuation multiples.
Wall Street Estimates
BIM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BIM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.